Perspective Therapeutics CATX
NYSE CATX
$2.98 -0.14 (-4.49%)
As of: Sep 9, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Asset Utilization Ratio (2011 - 2023)

Perspective Therapeutics' (CATX) quarterly Asset Utilization Ratio came in at 0.01 in Q4 2023, down 88.22% quarter-over-quarter from 0.12 in Q3 2023.

Analysis

Perspective Therapeutics (CATX) Asset Utilization Ratio (2011 - 2023) Analysis & Trends

Perspective Therapeutics has disclosed Asset Utilization Ratio across 12 years of filings, most recently posting 0.01 for Q4 2023.

  • In Q4 2023, Asset Utilization Ratio changed N/A year-over-year to 0.01; the TTM figure through Dec 2023 stood at 0.01 (changed N/A YoY), while the FY2023 annual figure was 0.02, changed N/A from the prior year.
  • Asset Utilization Ratio came in at 0.01 for Q4 2023 at Perspective Therapeutics, down from 0.12 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.17 in Q3 2020 to a low of 0.01 in Q4 2023.
  • Average Asset Utilization Ratio over 5 years is 0.47, with a median of 0.22 recorded in 2021.
  • Year-over-year, Asset Utilization Ratio tumbled 87.38% in 2021 and jumped 95.65% in 2022.
  • Over 5 years, Asset Utilization Ratio stood at 0.88 in 2019, then fell by 4.21% to 0.84 in 2020, then tumbled by 81.31% to 0.16 in 2021, then surged by 83.03% to 0.29 in 2022, then tumbled by 95.22% to 0.01 in 2023.
  • Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.01 in Q4 2023, 0.12 in Q3 2023, and 0.13 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 0.40
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 0.58
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 0.47
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 0.38
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 0.20
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 0.90
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 0.33
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 0.00
10 Perspective Therapeutics 361.95 Mn 361.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 0.01
Sep 30, 2023 0.12
Jun 30, 2023 0.13
Mar 31, 2023 0.19
Sep 30, 2022 0.29
Jun 30, 2022 0.21
Mar 31, 2022 0.16
Dec 31, 2021 0.16
Sep 30, 2021 0.15
Jun 30, 2021 0.14
Mar 31, 2021 0.22
Dec 31, 2020 0.84
Sep 30, 2020 1.17
Jun 30, 2020 1.10
Mar 31, 2020 1.04
Dec 31, 2019 0.88
Sep 30, 2019 0.83
Jun 30, 2019 0.73
Mar 31, 2019 0.62
Dec 31, 2018 0.53